Research by Johns Hopkins Kimmel Cancer Center specialists has uncovered a novel pathway in the origin of pancreatic cancers, one of the deadliest of malignancies. Their findings are reported in the June 23, 2003, issue of Cancer Cell.
Working with cancer cells from 55 patients, the Hopkins team found that a growth signal normally turned off in adult tissues is mistakenly turned back on after injury or inflammation of the pancreas. "We think reactivation may be a first step in initiating pancreatic cancer, well before the onset of any alterations to the pancreatic cells genetic material," says Steven D. Leach, M.D., Paul K. Neumann Professor in Pancreatic Cancer at the Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins and director of the study.
The Notch pathway, when functioning normally, regulates embryonic development in a wide variety of organisms, ranging from fruit flies to humans. In adult tissues, the pathway becomes dormant as cells become differentiated to perform specialized functions. But, when the pancreas is injured or diseased, Notch signaling may be reactivated in the adult pancreas, resulting in conversion of adult pancreas cells to cells similar to those seen in embryonic pancreas. These primitive cells accumulate in the epithelium, or lining, of the pancreas, setting the stage for the additional genetic changes that lead to cancer. "Using drugs to deactivate the Notch pathway could prevent these cancer-causing events from occurring," says Leach.
How cancer metastasis happens: Researchers reveal a key mechanism
19.01.2018 | Weill Cornell Medicine
Researchers identify new way to unmask melanoma cells to the immune system
17.01.2018 | Duke University Medical Center
08.01.2018 | Event News
11.12.2017 | Event News
08.12.2017 | Event News
19.01.2018 | Materials Sciences
19.01.2018 | Health and Medicine
19.01.2018 | Physics and Astronomy